BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36852874)

  • 1. COVID-19-Induced Changes in Photoplethysmography.
    Peck J; Wishon MJ; Wittels H; Hasty F; Hendricks S; Lee SJ; Wittels SH
    Mil Med; 2023 Jul; 188(7-8):e2661-e2669. PubMed ID: 36852874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercoagulable viscoelastic blood clot characteristics in critically ill coronavirus disease 2019 patients and associations with thrombotic complications.
    Roh DJ; Eiseman K; Kirsch H; Yoh N; Boehme A; Agarwal S; Park S; Connolly ES; Claassen J; Wagener G
    J Trauma Acute Care Surg; 2021 Jan; 90(1):e7-e12. PubMed ID: 33009340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-dimer Level and Diabetes in the COVID-19 Infection.
    Miri C; Charii H; Bouazzaoui MA; Laouan Brem F; Boulouiz S; Abda N; Kouismi H; Bazid Z; Ismaili N; El Ouafi N
    Clin Appl Thromb Hemost; 2021; 27():10760296211045902. PubMed ID: 34590493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of D-dimer elevation with inflammation and organ dysfunction in ICU patients with COVID-19 in Wuhan, China: a retrospective observational study.
    Zhang W; Sang L; Shi J; Zhong M; Jiang L; Song B; Kang L; Zhang Y; Zhang D; Yu Y; Zheng X
    Aging (Albany NY); 2021 Feb; 13(4):4794-4810. PubMed ID: 33591951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.
    Demelo-Rodríguez P; Cervilla-Muñoz E; Ordieres-Ortega L; Parra-Virto A; Toledano-Macías M; Toledo-Samaniego N; García-García A; García-Fernández-Bravo I; Ji Z; de-Miguel-Diez J; Álvarez-Sala-Walther LA; Del-Toro-Cervera J; Galeano-Valle F
    Thromb Res; 2020 Aug; 192():23-26. PubMed ID: 32405101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis.
    Rostami M; Khoshnegah Z; Mansouritorghabeh H
    Clin Appl Thromb Hemost; 2021; 27():10760296211010973. PubMed ID: 34933579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.
    Li JY; Wang HF; Yin P; Li D; Wang DL; Peng P; Wang WH; Wang L; Yuan XW; Xie JY; Zhou F; Xiong N; Shao F; Wang CX; Tong X; Ye H; Wan WJ; Liu BD; Li WZ; Li Q; Tang LV; Hu Y; Lip GYH;
    J Thromb Haemost; 2021 Apr; 19(4):1038-1048. PubMed ID: 33534149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventilation-Induced Modulation of Pulse Oximeter Waveforms: A Method for the Assessment of Early Changes in Intravascular Volume During Spinal Fusion Surgery in Pediatric Patients.
    Alian AA; Atteya G; Gaal D; Golembeski T; Smith BG; Dai F; Silverman DG; Shelley K
    Anesth Analg; 2016 Aug; 123(2):346-56. PubMed ID: 27284998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study.
    Grasselli G; Tonetti T; Protti A; Langer T; Girardis M; Bellani G; Laffey J; Carrafiello G; Carsana L; Rizzuto C; Zanella A; Scaravilli V; Pizzilli G; Grieco DL; Di Meglio L; de Pascale G; Lanza E; Monteduro F; Zompatori M; Filippini C; Locatelli F; Cecconi M; Fumagalli R; Nava S; Vincent JL; Antonelli M; Slutsky AS; Pesenti A; Ranieri VM;
    Lancet Respir Med; 2020 Dec; 8(12):1201-1208. PubMed ID: 32861276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo investigation of ear canal pulse oximetry during hypothermia.
    Budidha K; Kyriacou PA
    J Clin Monit Comput; 2018 Feb; 32(1):97-107. PubMed ID: 28130679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports.
    Manzoor D; Bui C; Makhoul E; Luthringer D; Marchevsky A; Volod O
    Medicine (Baltimore); 2021 Apr; 100(15):e25255. PubMed ID: 33847623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of soluble fibrin monomer complex in patients in SARS-CoV-2 COVID-19 infection-associated coagulopathy.
    Sridharan M; D Navitskas S; M Kock E; E Houghton D; M Heikal N; Chen D; K Pruthi R
    Eur J Haematol; 2022 Apr; 108(4):319-326. PubMed ID: 34921683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
    Nauka PC; Baron SW; Assa A; Mohrmann L; Jindal S; Oran E; Glazman-Kuczaj G; Southern WN; Chekuri S
    Thromb Res; 2021 Mar; 199():82-84. PubMed ID: 33476901
    [No Abstract]   [Full Text] [Related]  

  • 18. [Association of D-dimer, inflammatory markers, cytokines abnormality, and disease severity in COVID-19 severe/critical patients in Wuhan].
    Zhang J; Gao XL; Li DJ; Jiang Y; Liu Y; Pang L; Xu D; Yang LH
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):927-931. PubMed ID: 33333696
    [No Abstract]   [Full Text] [Related]  

  • 19. High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?
    Ibañez C; Perdomo J; Calvo A; Ferrando C; Reverter JC; Tassies D; Blasi A
    J Thromb Thrombolysis; 2021 Feb; 51(2):308-312. PubMed ID: 32671609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis.
    Fan BE; Ng J; Chan SSW; Christopher D; Tso ACY; Ling LM; Young BE; Wong LJL; Sum CLL; Tan HT; Ang MK; Lim GH; Ong KH; Kuperan P; Chia YW
    J Thromb Thrombolysis; 2021 Apr; 51(3):663-674. PubMed ID: 33098540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.